MCMohamed Chabbi

Mohamed Chabbi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mohamed Chabbi has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Yousra Mdarhri

    Department of Chemistry, Faculty of Science and Technology of Tangier, Abdelmalek Essaâdi University, Tetouan 93000, Morocco

    3 shared publications
  • Ahmed Touhami

    Department of Physics & Astronomy, College of Sciences, University of Texas Rio Grande Valley, Edinburg, TX 78539, USA

    2 shared publications
  • Narjisse Mokhtari

    Laboratory of Physical Chemistry of Materials, Natural Substances and Environment. Faculty of Sciences and Technologies of Tangier. Abdelmalek Essaadi University, Tetouan, Morocco

    2 shared publications
  • Abderrahman Bouassab

    Laboratory of Physical Chemistry of Materials, Natural Substances and Environment, Faculty of Sciences and Technologies of Tangier, Abdelmalek Essaadi University, Tanger 90010, Morocco

    1 shared publication
  • Camila De-Almeida-Perez-Pimenta

    Department of Pharmacology, Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, 15705 Santiago de Compostela, Spain

    1 shared publication
  • Fakhita Touhami

    Laboratory of Innovative Technology, Information and Communication Systems Department, National School of Applied Sciences of Tangier, Abdelmalek Essaadi University, Tétouan 93000, Morocco

    1 shared publication

Latest Publications

  • Open Access

    Encapsulation of Cannabidiol in Chitosan-Stabilized Argan Oil Nanoemulsion as a Potential Dermal Drug Delivery System for Psoriasis Treatment

    by Yousra Mdarhri, Vinicius De-Monte-Vidal, Camila De-Almeida-Perez-Pimenta, Selene Cuello-Rodríguez, Ahmed Touhami, Fakhita Touhami, Mohamed Chabbi, Victoria Díaz-Tomé

    Background: Cannabidiol (CBD), a non-psychoactive compound derived from Cannabis sativa, exhibits therapeutic potential for various conditions, including inflammation, pain, and skin disorders, making it a promising candidate for the topical treatment of psoriasis. However, its poor water solubility and instability limit its therapeutic efficacy. This study focuses on the development and characterization of CBD-loaded nanoemulsions using argan oil as the lipid phase, with and without a chitosan coating, which serves as a stabilizing and functional biopolymer. Methods: Nanoemulsions (NE) and chitosan-stabilized nanoemulsions (CS-NE), both without CBD (serving as controls), and CBD-loaded variants (CBD-NE and CBD-CS-NE) were prepared and characterized for their physicochemical properties, including pH, droplet size, polydispersity index (PDI), zeta potential (ζ-potential), and viscosity at various shear rates and temperatures. Stability was assessed over time, and drug release behavior was investigated through in vitro diffusion and ex vivo skin permeation studies, followed by kinetic modeling. Safety was evaluated through in vitro cytotoxicity assays using HaCaT keratinocyte cells, as well as in vivo toxicity studies using Caenorhabditis elegans (C. elegans). Results: The chitosan-coated formulations exhibited enhanced physical stability, nanoscale droplet size, a positive surface charge, and increased viscosity. Release studies demonstrated that CBD-CS-NE enabled controlled and sustained drug release, with a strong correlation to the Higuchi model, indicating diffusion-controlled permeation. Cytotoxicity assays indicated that CBD-CS-NE was non-toxic to cultured cells, while in vivo testing with C. elegans revealed sensitivity to chitosan-coated systems. Conclusions: These findings highlight the potential of CBD-loaded argan oil nanoemulsions, particularly those stabilized with chitosan, as potential topical delivery systems for managing psoriasis.


  • Open Access

    Sustained Antifungal Protection of Peanuts Using Encapsulated Essential Oils

    by Narjisse Mokhtari, Hammadi El Farissi, Francesco Cacciola, Yousra Mdarhri, Abderrahman Bouassab, Mohamed Chabbi

    Essential oils (EOs) are promising bio-preservatives for oilseeds; however, their high volatility and strong aroma limit practical applications. In this study, we developed a dual-size microencapsulated formulation of oregano (Origanum compactum) and myrtle (Myrthus communis) EOs (75:25, w/w) using gelatin–gum arabic complex coacervation, and evaluated its antifungal efficacy and effect on seed viability in peanuts. GC-MS analysis of the EO blend identified carvacrol (33.83%) as the dominant constituent. The microcapsules exhibited an encapsulation efficiency of 83.56% and were produced in a 70% small/30% large particle ratio to ensure both immediate and sustained vapor release. In vapor-phase assays against toxigenic A. flavus (RP-6), both free and encapsulated EOs inhibited fungal growth in a dose-dependent manner and achieved complete suppression at concentrations ≥0.2 µL mL−1, whereas the wall material alone showed no activity. In a 120-day microcosm storage experiment (0.2 mg EO g−1 kernels; 0.96 mg microcapsules g−1), treated peanuts showed an immediate reduction in total fungal load from 3.52 to 1.48 log10 CFU g−1 (≈58%), which stabilized near 1.42–1.43 log10 CFU g−1 up to 90 days, while the control samples increased to 4.25 log10 CFU g−1 by day 120. The formulation effectively suppressed major storage fungi, including Aspergillus sections Flavi and Nigri, Penicillium spp., Rhizopus, Fusarium, and Alternaria. The antioxidant activity (DPPH assay) was retained after encapsulation (IC50: 0.52 mg mL−1 encapsulated vs. 0.58 mg mL−1 free). Germination power remained comparable to the control throughout storage (≈50–52%), indicating no adverse impact on seed viability. These findings demonstrate that vapor-active, dual-size microencapsulation of oregano-myrtle EOs offers a practical and sustainable approach to enhance peanut safety during storage without compromising germination potential.


  • Open Access

    Stabilization of Argan Oil Nanoemulsions Using Chitosan Extracted from Pink Shrimp Shells

    by Yousra Mdarhri, Ikram Bouziane, Ilyace Korodowou, Narjisse Mokhtari, Lama Rissouli, Fakhita Touhami, Mohamed Chabbi, Ahmed Touhami

    This study investigates the use of chitosan, extracted from pink shrimp shells, as a stabilizer for argan oil nanoemulsions. Chitosan was obtained through demineralization, deproteination, bleaching, deacetylation, and purification, then characterized through potentiometric titration, viscometry, X-ray diffraction (XRD), scanning electron microscopy (SEM), and purity assessments. The resulting chitosan was used to stabilize nanoemulsions formulated with extra-virgin argan oil and a nonionic surfactant using the phase inversion composition (PIC) method. The stability of the nanoemulsion was assessed through light scattering, zeta potential, viscosity, and pH measurements. The extracted chitosan exhibited high purity, a deacetylation degree of 88.34%, a molecular weight of 408.809 kDa, and a crystalline index of 66.36%. Chitosan significantly improved nanoemulsion stability, maintaining droplet integrity for over six months at 40 °C. Higher chitosan concentrations increased droplet size, viscosity, and stability, indicating strong polymer adsorption. These findings demonstrate the potential of shrimp waste-derived chitosan as a sustainable stabilizer for argan oil nanoemulsions, promoting effective bioactive compound delivery and environmental sustainability.